Acute Bilateral Uveitis, Hypotony, and Cataracts Associated with Ipilimumab and Nivolumab Therapy: Optical Coherence Tomography Angiography Findings
Immune checkpoint inhibitors are increasingly being used for the treatment of several malignancies. In rare cases, patients develop disabling ophthalmic side effects such as dry eyes, episcleritis, keratitis, uveitis, inflammatory orbitopathy, myasthenia gravis, macular edema, and serous retinal det...
Main Authors: | Jessica C. Lee, Ghadeer Al-Humimat, Karanjit S. Kooner |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2020-11-01
|
Series: | Case Reports in Ophthalmology |
Subjects: | |
Online Access: | https://www.karger.com/Article/FullText/509629 |
Similar Items
-
A Case of Vogt-Koyanagi-Harada Disease-Like Uveitis Induced by Nivolumab and Ipilimumab Combination Therapy
by: Keisuke Minami, et al.
Published: (2021-12-01) -
Uveitis-induced Refractory Ocular Hypotony Managed with High-dose Latanoprost
by: Fariba Ghassemi, et al.
Published: (2020-08-01) -
Ipilimumab and nivolumab for recurrent neuroendocrine cervical carcinoma
by: Mary Towner, et al.
Published: (2022-08-01) -
Ipilimumab-related uveitis and refractory hypotony with a flat chamber in a trabeculectomized eye with exfoliation glaucoma: A case report
by: Naofumi Funagura, et al.
Published: (2023-03-01) -
Ocular hypertension and hypotony as determinates of outcomes in uveitis
by: Aman R, et al.
Published: (2015-12-01)